In a peer-reviewed publication
of 5-year follow-up on a 27 patient cohort from Cartiva's pivotal
clinical trial, functional outcomes improved significantly, pain was reduced significantly, and
Cartiva demonstrated excellent durability and survivorship at five years post-surgery. Furthermore,
patients maintained their great toe motion and were satisfied, with 96% of patients indicating
they would undergo the procedure again.
The following tables demonstrate the 5-year outcomes for Cartiva.